Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers

2024-12-1

Preferences of US adolescents and parents for vaccination against invasive meningococcal disease

2024-11-1

Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial

2024-11-1

Vaccination with a Lawsonia intracellularis subunit water in oil emulsion vaccine mitigated some disease parameters but failed to affect shedding

2024-10-1

Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine

2024-10-1

COVID-19 vaccine hesitancy: Meaning relations between responses in an epidemiological study and twitter messages

2024-10-1

Evaluation of interventions to improve timely hepatitis B birth dose vaccination among infants and maternal tetanus vaccination among pregnant women in Nigeria

2024-10-1

Pneumococcal carriage and changes in serotype distribution post- PCV13 introduction in children in Matiari, Pakistan

2024-10-1

Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)

2024-10-1

The EEHV1A gH/gL complex elicits humoral and cell-mediated immune responses in mice

2024-10-1

Iridaea cordata lipid extract associated with the rCP01850 protein of C. pseudotuberculosis elicited a Th1 immune response in immunized sheep

2024-10-1

Identification of gene and protein signatures associated with long-term effects of COVID-19 on the immune system after patient recovery by analyzing single-cell multi-omics data using a machine learning approach

2024-10-1

Determinants of undervaccination of routine childhood immunization in Argentina: A cross-sectional study

2024-10-1

Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China

2024-10-1

Operationalizing the Behaviour Change Wheel and APEASE criteria to co-develop recommendations with stakeholders to address barriers to school-based immunization programs

2024-10-1

Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity

2024-10-1

Characterization of a triple-type chimeric vaccine against human papillomavirus types 18, 45, and 59

2024-10-1

Predictors of the willingness to accept a free COVID-19 vaccine among households in Nigeria

2024-10-1

Preferences for a Clostridioides difficile vaccine among adults in the United States

2024-10-1

Vaccination with a trivalent Klebsiella pneumoniae vaccine confers protection in a murine model of pneumonia

2024-10-1

Understanding hepatitis E vaccination intention among women of childbearing-age: A theory-based cross-sectional study

2024-10-1

Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge

2024-10-1

Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience

2024-10-1

Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus

2024-10-1

Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY)

2024-10-1

Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: Prospective cohort study

2024-10-1

Enhancing NA immunogenicity through novel VLP designs.

2024-10-1

Onward transmission of measles virus among vaccinated cases in a large community outbreak in Auckland, New Zealand, 2019

2024-10-1

Confidence and barriers: Analysis of factors associated with timely routine childhood vaccination in Canada during the COVID-19 pandemic

2024-10-1

Generation and evaluation of Salmonella entericaserovar Choleraesuis mutant strains as a potential live-attenuated vaccine

2024-10-1

Measles immunity status in Iranian infants and children and outbreak concerns: Time for reconsidering the vaccination schedule?

2024-10-1

mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells

2024-10-1

A second-generation recombinant BCG strain combines protection against murine tuberculosis with an enhanced safety profile in immunocompromised hosts

2024-10-1

A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters

2024-10-1

Disparities in COVID-19 vaccination receipt by race, ethnicity, and social determinants of health among a large patient population in a network of community-based healthcare centers

2024-10-1

Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study

2024-10-1

Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March – December 2021

2024-10-1

Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight

2024-10-1

Shedding reduction and immunity modulation in piglets with an inactivated Mycoplasma hyopneumoniae vaccine encapsulated in nanostructured SBA-15 silica

2024-10-1

Vaccination uptake in LGBTQ adults in two US states: Findings from the QVax study

2024-9-14

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June – 1 July 2024

2024-9-14

Measuring the impact of influenza vaccination in the Netherlands using retrospective observational primary care, hospitalisation and mortality data

2024-9-14

Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine

2024-9-13

Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study

2024-9-13

Whole-genome sequencing of Neisseria meningitidis collected in Chile from pediatric patients during 2016–2019 and coverage vaccine prediction

2024-9-13

Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection

2024-9-12

Analysis of health claims data on vaccination coverage in older adults in Bavaria, Germany: Influenza, pneumococcus and herpes zoster

2024-9-12

Editorial Board

2024-9-11

Editorial Board

2024-9-11

Modeling conjugate vaccine and natural induced antibody correlates of protection for pneumococcal colonization and acute otitis media infection in young children

2024-9-11